Arteris (AIP) is back in focus after first quarter 2026 earnings showed revenue of US$22.94 million versus US$16.53 million a year earlier, alongside raised full year guidance and record contract metrics tied to AI focused customers.

The latest earnings beat, raised guidance and AI focused contract wins have come alongside sharp share price swings, with a 66.06% 1 month share price return and a very large 1 year total shareholder return. Together these point to strong, but volatile, momentum.

If Arteris’s run has you thinking about where AI related capital could move next, it is worth scanning other potential opportunities across 42 AI infrastructure stocks

With Arteris now valued at about US$1.7b, a recent share price of US$33.71 and a value score of 0 despite strong contract metrics and raised guidance, is there still a sensible entry point here, or is the market already pricing in the future?

Most Popular Narrative: 64.4% Overvalued

Arteris closed at $33.71 while the most followed narrative points to a fair value of $20.50, so the story here hinges on whether the current price fully reflects its growth potential.

The ongoing industry transition to chiplet-based and heterogeneous integration architectures is expanding Arteris' addressable market, with chiplet-related design starts expected to rise from 5% to 30% in coming years; this structural trend supports both higher sales volume and increased average selling prices, benefiting future top-line revenue.

Curious how a fast growing top line, a step change in margins and a premium future earnings multiple are all wired together in this valuation story.

Result: Fair Value of $20.50 (OVERVALUED)

However, that story can quickly change if large customers pull back on outsourcing or if rising R&D and field engineering costs outpace revenue and delay margin progress.

Next Steps

With sentiment clearly split between risk and reward, this is a good moment to look through the numbers yourself and decide where you stand. To weigh both sides in one place, start with the 1 key reward and 2 important warning signs

Looking for more investment ideas?

If Arteris has sharpened your focus, do not stop here. Broaden your watchlist with other focused ideas that could suit your style and risk tolerance.

• Target resilient balance sheets by checking companies filtered through the solid balance sheet and fundamentals stocks screener (45 results).
• Pursue mispriced quality by scanning opportunities surfaced in the 50 high quality undervalued stocks.
• Aim for steadier portfolio income by reviewing stocks highlighted in the 12 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.